PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,158,553 | -14.5% | 70,357 | +11.7% | 0.01% | -11.1% |
| Q2 2023 | $2,524,330 | +12.7% | 62,998 | +14.8% | 0.01% | +12.5% |
| Q1 2023 | $2,239,734 | +21.9% | 54,882 | +15.4% | 0.01% | +14.3% |
| Q4 2022 | $1,836,909 | -17.9% | 47,576 | +13.1% | 0.01% | -22.2% |
| Q3 2022 | $2,237,000 | +7.4% | 42,061 | +17.7% | 0.01% | +12.5% |
| Q2 2022 | $2,083,000 | -32.3% | 35,724 | -11.4% | 0.01% | -20.0% |
| Q1 2022 | $3,076,000 | +1.4% | 40,300 | -20.1% | 0.01% | +11.1% |
| Q4 2021 | $3,033,000 | +12.4% | 50,415 | +4.6% | 0.01% | +12.5% |
| Q3 2021 | $2,698,000 | +12.6% | 48,176 | +21.9% | 0.01% | 0.0% |
| Q2 2021 | $2,397,000 | +10.0% | 39,509 | +27.1% | 0.01% | 0.0% |
| Q1 2021 | $2,179,000 | -6.9% | 31,092 | -20.5% | 0.01% | 0.0% |
| Q4 2020 | $2,341,000 | +4.1% | 39,121 | +4.6% | 0.01% | -11.1% |
| Q3 2020 | $2,248,000 | -6.5% | 37,390 | -18.4% | 0.01% | -10.0% |
| Q2 2020 | $2,403,000 | +39.8% | 45,802 | -10.6% | 0.01% | +25.0% |
| Q1 2020 | $1,719,000 | -26.0% | 51,258 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $2,322,000 | +9.5% | 51,258 | -8.0% | 0.01% | +12.5% |
| Q3 2019 | $2,120,000 | – | 55,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |